subject: PUBCHEM.COMPOUND:51038893

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: B-cell small lymphocytic lymphoma recurrent

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:51038893

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:51038893

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:51038893

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:51038893

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:51038893

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:51038893

object_name: anemia


subject: PUBCHEM.COMPOUND:51038893

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:51038893

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135565596

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:135565596

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:135565596

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:135565596

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:135565596


subject: PUBCHEM.COMPOUND:135565596

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:135565596

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:135565596

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:135565596

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:135565596

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:135565596

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:135565596

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:135565596

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: anemia


subject: PUBCHEM.COMPOUND:135565596

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:135565596

object_name: myelofibrosis


subject: CHEBI:173077

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:173077

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:173077

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:173077

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:173077

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:173077

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:173077

object_name: Blast Phase


subject: CHEBI:173077

object_name: castration-resistant prostate carcinoma


subject: CHEBI:173077

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:173077


subject: CHEBI:173077

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:173077

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:173077

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:173077

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:173077

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:173077

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:173077

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:173077

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:173077

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:173077

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:173077

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:173077

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:173077

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:173077

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:173077

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:173077

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:173077

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:173077

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:173077

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:173077

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:173077

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:173077

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:173077

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:173077

object_name: refractory hematologic cancer


subject: CHEBI:173077

object_name: Refractory acute myeloid leukemia


subject: CHEBI:173077

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:173077

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:173077

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:173077

object_name: anemia


subject: CHEBI:173077

object_name: Anemia, CTCAE


subject: CHEBI:173077

object_name: myelofibrosis


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:75045

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:75045

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:75045

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:75045

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:75045

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:75045

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:75045

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:75045

object_name: Blast Phase


subject: CHEBI:75045

object_name: castration-resistant prostate carcinoma


subject: CHEBI:75045

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:75045


subject: CHEBI:75045

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:75045

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:75045

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:75045

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:75045

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:75045

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:75045

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:75045

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:75045

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:75045

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:75045

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:75045

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:75045

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:75045

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:75045

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:75045

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:75045

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:75045

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:75045

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:75045

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:75045

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:75045

object_name: refractory hematologic cancer


subject: CHEBI:75045

object_name: Refractory acute myeloid leukemia


subject: CHEBI:75045

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:75045

object_name: Metastatic Breast Carcinoma


subject: CHEBI:75045

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:75045

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:75045

object_name: anemia


subject: CHEBI:75045

object_name: Anemia, CTCAE


subject: CHEBI:75045

object_name: myelofibrosis


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:132268

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:132268

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:132268

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:132268

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:132268

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:132268

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:132268

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:132268

object_name: Blast Phase


subject: CHEBI:132268

object_name: castration-resistant prostate carcinoma


subject: CHEBI:132268

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:132268


subject: CHEBI:132268

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:132268

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:132268

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:132268

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:132268

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:132268

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:132268

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:132268

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:132268

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:132268

object_name: Plasma cell myeloma recurrent


subject: CHEBI:132268

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:132268

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:132268

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:132268

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:132268

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:132268

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:132268

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:132268

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:132268

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:132268

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:132268

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:132268

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:132268

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:132268

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:132268

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:132268

object_name: refractory hematologic cancer


subject: CHEBI:132268

object_name: Refractory acute myeloid leukemia


subject: CHEBI:132268

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:132268

object_name: Plasma cell myeloma refractory


subject: CHEBI:132268

object_name: Metastatic Breast Carcinoma


subject: CHEBI:132268

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:132268

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:132268

object_name: anemia


subject: CHEBI:132268

object_name: Anemia, CTCAE


subject: CHEBI:132268

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:121489720

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:121489720

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:121489720

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:121489720

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:121489720

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:121489720

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:121489720

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:121489720


subject: PUBCHEM.COMPOUND:121489720

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:121489720

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:121489720

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:121489720

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:121489720

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:121489720

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:121489720

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:121489720

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:121489720

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:121489720

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:121489720

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:121489720

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:121489720

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:121489720

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:121489720

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:121489720

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:121489720

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:121489720

object_name: anemia


subject: PUBCHEM.COMPOUND:121489720

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:121489720

object_name: myelofibrosis


subject: CHEBI:70839

subject_name: Dasatinib

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:70839

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:70839


subject: CHEBI:70839

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:70839

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:70839

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:70839

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:70839

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:70839

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:70839

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:70839

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:70839

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:70839

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:70839

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:70839

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:70839

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:70839

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:70839

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:70839

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:70839

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:70839

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:70839

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:70839

object_name: refractory hematologic cancer


subject: CHEBI:70839

object_name: Refractory acute myeloid leukemia


subject: CHEBI:70839

object_name: Metastatic Breast Carcinoma


subject: CHEBI:70839

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:70839

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:70839

object_name: anemia


subject: CHEBI:70839

object_name: Anemia, CTCAE


subject: CHEBI:70839

object_name: myelofibrosis


subject: CHEBI:190514

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:190514

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:190514


subject: CHEBI:190514

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:190514

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:190514

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:190514

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:190514

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:190514

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:190514

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:190514

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:190514

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:190514

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:190514

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:190514

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:190514

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:190514

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:190514

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:190514

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:190514

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:190514

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:190514

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:190514

object_name: refractory hematologic cancer


subject: CHEBI:190514

object_name: Refractory acute myeloid leukemia


subject: CHEBI:190514

object_name: Metastatic Breast Carcinoma


subject: CHEBI:190514

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:190514

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:190514

object_name: anemia


subject: CHEBI:190514

object_name: Anemia, CTCAE


subject: CHEBI:190514

object_name: myelofibrosis


subject: CHEBI:49375

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:49375

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:49375


subject: CHEBI:49375

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:49375

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:49375

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:49375

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:49375

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:49375

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:49375

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:49375

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:49375

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:49375

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:49375

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:49375

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:49375

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:49375

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:49375

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:49375

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:49375

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:49375

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:49375

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:49375

object_name: refractory hematologic cancer


subject: CHEBI:49375

object_name: Refractory acute myeloid leukemia


subject: CHEBI:49375

object_name: Metastatic Breast Carcinoma


subject: CHEBI:49375

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:49375

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:49375

object_name: anemia


subject: CHEBI:49375

object_name: Anemia, CTCAE


subject: CHEBI:49375

object_name: myelofibrosis


subject: CHEBI:64816

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:64816

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:64816

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:64816

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:64816

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:64816

object_name: castration-resistant prostate carcinoma


subject: CHEBI:64816

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:64816

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:64816

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:64816

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:64816

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:64816

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:64816

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:64816

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:64816

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:64816

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:64816

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:64816

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:64816

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:64816

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:64816

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:64816

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:64816

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:64816

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:64816

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:64816

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:64816

object_name: refractory hematologic cancer


subject: CHEBI:64816

object_name: Refractory acute myeloid leukemia


subject: CHEBI:64816

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:64816

object_name: Plasma cell myeloma refractory


subject: CHEBI:64816

object_name: Metastatic Breast Carcinoma


subject: CHEBI:64816

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:64816

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:64816

object_name: anemia


subject: CHEBI:64816

object_name: Anemia, CTCAE


subject: CHEBI:64816

object_name: myelofibrosis


subject: CHEBI:91872

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:91872

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:91872

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:91872

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:91872

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:91872

object_name: castration-resistant prostate carcinoma


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:91872

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:91872

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:91872

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:91872

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:91872

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:91872

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:91872

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:91872

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:91872

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:91872

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:91872

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:91872

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:91872

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:91872

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:91872

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:91872

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:91872

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:91872

object_name: refractory hematologic cancer


subject: CHEBI:91872

object_name: Refractory acute myeloid leukemia


subject: CHEBI:91872

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:91872

object_name: Plasma cell myeloma refractory


subject: CHEBI:91872

object_name: Metastatic Breast Carcinoma


subject: CHEBI:91872

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:91872

object_name: anemia


subject: CHEBI:91872

object_name: Anemia, CTCAE


subject: CHEBI:91872

object_name: myelofibrosis


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:28748

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:28748

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:28748

object_name: castration-resistant prostate carcinoma


subject: CHEBI:28748


subject: CHEBI:28748

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:28748

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:28748

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:28748

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:28748

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:28748

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:28748

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:28748

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:28748

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:28748

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:28748

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:28748

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:28748

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:28748

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:28748

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:28748

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:28748

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:28748

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:28748

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:28748

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:28748

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:28748

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:28748

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:28748

object_name: refractory hematologic cancer


subject: CHEBI:28748

object_name: Refractory acute myeloid leukemia


subject: CHEBI:28748

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:28748

object_name: Metastatic Breast Carcinoma


subject: CHEBI:28748

object_name: anemia


subject: CHEBI:28748

object_name: Anemia, CTCAE


subject: CHEBI:28748

object_name: myelofibrosis


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UNII:28X28X9OKV

object_name: leukemia, myeloid, accelerated-phase


subject: UNII:28X28X9OKV

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UNII:28X28X9OKV

object_name: Blast Phase


subject: UNII:28X28X9OKV

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:28X28X9OKV

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:28X28X9OKV

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UNII:28X28X9OKV

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:28X28X9OKV

object_name: Recurrent Myeloproliferative Neoplasm


subject: UNII:28X28X9OKV

object_name: Recurrent Hematologic Malignancy


subject: UNII:28X28X9OKV

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:28X28X9OKV

object_name: Plasma cell myeloma recurrent


subject: UNII:28X28X9OKV

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:28X28X9OKV

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:28X28X9OKV

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UNII:28X28X9OKV

object_name: Recurrent Myelodysplastic Syndrome


subject: UNII:28X28X9OKV

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UNII:28X28X9OKV

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:28X28X9OKV

object_name: Stage III Non-Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:28X28X9OKV

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:28X28X9OKV

object_name: Recurrent Acute Myeloid Leukemia


subject: UNII:28X28X9OKV

object_name: Refractory Primary Myelofibrosis


subject: UNII:28X28X9OKV

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Refractory Malignant Solid Neoplasm


subject: UNII:28X28X9OKV

object_name: Stage III Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Refractory Myelodysplastic Syndrome


subject: UNII:28X28X9OKV

object_name: Stage IV Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: refractory hematologic cancer


subject: UNII:28X28X9OKV

object_name: Refractory acute myeloid leukemia


subject: UNII:28X28X9OKV

object_name: Non-Hodgkin's lymphoma refractory


subject: UNII:28X28X9OKV

object_name: Plasma cell myeloma refractory


subject: UNII:28X28X9OKV

object_name: Metastatic Breast Carcinoma


subject: UNII:28X28X9OKV

object_name: Refractory Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UNII:28X28X9OKV

object_name: anemia


subject: UNII:28X28X9OKV

object_name: Anemia, CTCAE


subject: UMLS:C3641122

object_name: myelodysplastic syndrome with ring sideroblasts


subject: UMLS:C3641122

object_name: leukemia, myeloid, accelerated-phase


subject: UMLS:C3641122

object_name: Leukemia, Myeloid, Chronic-Phase


subject: UMLS:C3641122

object_name: Blast Phase


subject: UMLS:C3641122

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C3641122


subject: UMLS:C3641122

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UMLS:C3641122

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UMLS:C3641122

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: UMLS:C3641122

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UMLS:C3641122

object_name: Recurrent Myeloproliferative Neoplasm


subject: UMLS:C3641122

object_name: Recurrent Hematologic Malignancy


subject: UMLS:C3641122

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: UMLS:C3641122

object_name: Acute lymphoblastic leukemia recurrent


subject: UMLS:C3641122

object_name: Plasma cell myeloma recurrent


subject: UMLS:C3641122

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C3641122

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UMLS:C3641122

object_name: Recurrent Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Unresectable Pancreatic Adenocarcinoma


subject: UMLS:C3641122

object_name: Recurrent Myelodysplastic Syndrome


subject: UMLS:C3641122

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: UMLS:C3641122

object_name: B-cell small lymphocytic lymphoma refractory


subject: UMLS:C3641122

object_name: Stage III Non-Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UMLS:C3641122

object_name: Chronic lymphocytic leukaemia refractory


subject: UMLS:C3641122

object_name: Recurrent Acute Myeloid Leukemia


subject: UMLS:C3641122

object_name: Refractory Primary Myelofibrosis


subject: UMLS:C3641122

object_name: Stage IV Non-Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Refractory Malignant Solid Neoplasm


subject: UMLS:C3641122

object_name: Stage III Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Refractory Myelodysplastic Syndrome


subject: UMLS:C3641122

object_name: Stage IV Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: refractory hematologic cancer


subject: UMLS:C3641122

object_name: Refractory acute myeloid leukemia


subject: UMLS:C3641122

object_name: Non-Hodgkin's lymphoma refractory


subject: UMLS:C3641122

object_name: Plasma cell myeloma refractory


subject: UMLS:C3641122

object_name: Metastatic Breast Carcinoma


subject: UMLS:C3641122

object_name: Refractory Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: Refractory Childhood Hodgkin Lymphoma


subject: UMLS:C3641122

object_name: anemia


subject: UMLS:C3641122

object_name: Anemia, CTCAE


subject: CHEBI:145374

subject_name: Enasidenib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:145374

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:145374

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:145374

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:145374

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:145374

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:145374

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:145374

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:145374

object_name: Blast Phase


subject: CHEBI:145374

object_name: castration-resistant prostate carcinoma


subject: CHEBI:145374

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:145374


subject: CHEBI:145374

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:145374

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:145374

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:145374

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:145374

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:145374

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:145374

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:145374

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:145374

object_name: Plasma cell myeloma recurrent


subject: CHEBI:145374

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:145374

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:145374

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:145374

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:145374

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:145374

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:145374

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:145374

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:145374

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:145374

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:145374

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:145374

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:145374

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:145374

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:145374

object_name: refractory hematologic cancer


subject: CHEBI:145374

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:145374

object_name: Plasma cell myeloma refractory


subject: CHEBI:145374

object_name: Metastatic Breast Carcinoma


subject: CHEBI:145374

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:145374

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:145374

object_name: anemia


subject: CHEBI:145374

object_name: Anemia, CTCAE


subject: CHEBI:145374

object_name: myelofibrosis


subject: CHEBI:195558

subject_name: Entrectinib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:195558

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:195558

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:195558

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:195558

object_name: Blast Phase


subject: CHEBI:195558

object_name: castration-resistant prostate carcinoma


subject: CHEBI:195558

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:195558


subject: CHEBI:195558

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:195558

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:195558

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:195558

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:195558

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:195558

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:195558

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:195558

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:195558

object_name: Plasma cell myeloma recurrent


subject: CHEBI:195558

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:195558

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:195558

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:195558

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:195558

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:195558

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:195558

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:195558

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:195558

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:195558

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:195558

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:195558

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:195558

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:195558

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:195558

object_name: refractory hematologic cancer


subject: CHEBI:195558

object_name: Refractory acute myeloid leukemia


subject: CHEBI:195558

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:195558

object_name: Plasma cell myeloma refractory


subject: CHEBI:195558

object_name: Metastatic Breast Carcinoma


subject: CHEBI:195558

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:195558

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:195558

object_name: anemia


subject: CHEBI:195558

object_name: Anemia, CTCAE


subject: CHEBI:195558

object_name: myelofibrosis


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:68534

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:68534

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:68534

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:68534

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:68534

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:68534

object_name: Blast Phase


subject: CHEBI:68534

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:68534


subject: CHEBI:68534

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:68534

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:68534

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:68534

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:68534

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:68534

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:68534

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:68534

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:68534

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:68534

object_name: Plasma cell myeloma recurrent


subject: CHEBI:68534

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:68534

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:68534

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:68534

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:68534

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:68534

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:68534

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:68534

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:68534

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:68534

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:68534

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:68534

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:68534

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:68534

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:68534

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:68534

object_name: refractory hematologic cancer


subject: CHEBI:68534

object_name: Refractory acute myeloid leukemia


subject: CHEBI:68534

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:68534

object_name: Plasma cell myeloma refractory


subject: CHEBI:68534

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:68534

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:68534

object_name: anemia


subject: CHEBI:68534

object_name: Anemia, CTCAE


subject: CHEBI:68534

object_name: myelofibrosis


subject: CHEBI:114785

subject_name: Erlotinib

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:114785

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:114785

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:114785

object_name: Blast Phase


subject: CHEBI:114785

object_name: castration-resistant prostate carcinoma


subject: CHEBI:114785

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:114785


subject: CHEBI:114785

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:114785

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:114785

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:114785

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:114785

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:114785

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:114785

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:114785

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:114785

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:114785

object_name: Plasma cell myeloma recurrent


subject: CHEBI:114785

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:114785

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:114785

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:114785

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:114785

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:114785

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:114785

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:114785

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:114785

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:114785

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:114785

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:114785

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:114785

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:114785

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:114785

object_name: refractory hematologic cancer


subject: CHEBI:114785

object_name: Refractory acute myeloid leukemia


subject: CHEBI:114785

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:114785

object_name: Plasma cell myeloma refractory


subject: CHEBI:114785

object_name: Metastatic Breast Carcinoma


subject: CHEBI:114785

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:114785

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:114785

object_name: anemia


subject: CHEBI:114785

object_name: Anemia, CTCAE


subject: CHEBI:114785

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:70789204

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:70789204

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:70789204

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:70789204

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:70789204

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:70789204

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:70789204

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:70789204

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:70789204

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: anemia


subject: PUBCHEM.COMPOUND:70789204

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:14907381

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:14907381

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:14907381

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:14907381

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:14907381

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:14907381

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:14907381

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:14907381

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:14907381

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:14907381

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:14907381

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:14907381

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:14907381

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: anemia


subject: PUBCHEM.COMPOUND:14907381

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:14907381

object_name: myelofibrosis


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:46345

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:46345

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:46345

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:46345

object_name: Blast Phase


subject: CHEBI:46345

object_name: castration-resistant prostate carcinoma


subject: CHEBI:46345

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:46345


subject: CHEBI:46345

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:46345

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:46345

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:46345

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:46345

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:46345

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:46345

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:46345

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:46345

object_name: Plasma cell myeloma recurrent


subject: CHEBI:46345

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:46345

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:46345

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:46345

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:46345

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:46345

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:46345

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:46345

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:46345

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:46345

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:46345

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:46345

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:46345

object_name: refractory hematologic cancer


subject: CHEBI:46345

object_name: Refractory acute myeloid leukemia


subject: CHEBI:46345

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:46345

object_name: Plasma cell myeloma refractory


subject: CHEBI:46345

object_name: Metastatic Breast Carcinoma


subject: CHEBI:46345

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:46345

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:46345

object_name: anemia


subject: CHEBI:46345

object_name: Anemia, CTCAE


subject: CHEBI:46345

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:11654566

subject_name: Idelalisib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:11654566

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage III Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:11654566

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:11654566

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:11654566

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:11654566

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:11654566


subject: PUBCHEM.COMPOUND:11654566

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:11654566

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:11654566

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:11654566

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Acute lymphoblastic leukemia recurrent


subject: PUBCHEM.COMPOUND:11654566

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Unresectable Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:11654566

object_name: Recurrent Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:11654566

object_name: Metastatic Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:11654566

object_name: Pancreatic adenocarcinoma metastatic


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:11654566

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory acute myeloid leukemia


subject: PUBCHEM.COMPOUND:11654566

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:11654566

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:11654566

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:11654566

object_name: anemia


subject: PUBCHEM.COMPOUND:11654566

object_name: Anemia, CTCAE


subject: CHEBI:45783

subject_name: Imatinib

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:45783

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:45783

object_name: Stage II Pancreatic Cancer AJCC v8


subject: CHEBI:45783

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:45783

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:45783

object_name: castration-resistant prostate carcinoma


subject: CHEBI:45783


subject: CHEBI:45783

tested_intervention: yes


subject: CHEBI:45783

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:45783

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:45783

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:45783

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:45783

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:45783

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:45783

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:45783

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:45783

object_name: Plasma cell myeloma recurrent


subject: CHEBI:45783

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:45783

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:45783

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:45783

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:45783

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:45783

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:45783

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:45783

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:45783

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:45783

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:45783

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:45783

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:45783

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:45783

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:45783

object_name: refractory hematologic cancer


subject: CHEBI:45783

object_name: Refractory acute myeloid leukemia


subject: CHEBI:45783

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:45783

object_name: Plasma cell myeloma refractory


subject: CHEBI:45783

object_name: Metastatic Breast Carcinoma


subject: CHEBI:45783

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:45783

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:45783

object_name: anemia


subject: CHEBI:45783

object_name: Anemia, CTCAE


subject: CHEBI:231679

subject_name: ipilimumab

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:231679

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:231679

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:231679

object_name: Blast Phase


subject: CHEBI:231679


subject: CHEBI:231679

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:231679

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:231679

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:231679

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:231679

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:231679

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:231679

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:231679

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:231679

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:231679

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:231679

object_name: refractory hematologic cancer


subject: CHEBI:231679

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:231679

object_name: Metastatic Breast Carcinoma


subject: CHEBI:231679

object_name: anemia


subject: CHEBI:231679

object_name: Anemia, CTCAE


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:85994

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:85994

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:85994

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:85994

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:85994

object_name: Blast Phase


subject: CHEBI:85994

object_name: castration-resistant prostate carcinoma


subject: CHEBI:85994

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:85994


subject: CHEBI:85994

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:85994

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:85994

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:85994

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:85994

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:85994

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:85994

object_name: Locally Advanced Pancreatic Adenocarcinoma


subject: CHEBI:85994

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:85994

object_name: Plasma cell myeloma recurrent


subject: CHEBI:85994

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:85994

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:85994

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Unresectable Pancreatic Adenocarcinoma


subject: CHEBI:85994

object_name: Recurrent Myelodysplastic Syndrome


subject: CHEBI:85994

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: CHEBI:85994

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:85994

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:85994

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:85994

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:85994

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:85994

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:85994

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:85994

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Refractory Myelodysplastic Syndrome


subject: CHEBI:85994

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:85994

object_name: refractory hematologic cancer


subject: CHEBI:85994

object_name: Refractory acute myeloid leukemia


subject: CHEBI:85994

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:85994

object_name: Plasma cell myeloma refractory


subject: CHEBI:85994

object_name: Metastatic Breast Carcinoma


subject: CHEBI:85994

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:85994

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:85994

object_name: anemia


subject: CHEBI:85994

object_name: Anemia, CTCAE


subject: CHEBI:85994

object_name: myelofibrosis


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:191174

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:191174

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:191174

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:191174

object_name: Blast Phase


subject: CHEBI:191174

object_name: castration-resistant prostate carcinoma


subject: CHEBI:191174

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:191174


subject: CHEBI:191174

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:191174

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:191174

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:191174

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:191174

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:191174

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:191174

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:191174

object_name: Plasma cell myeloma recurrent


subject: CHEBI:191174

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:191174

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:191174

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:191174

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:191174

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:191174

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:191174

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:191174

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:191174

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:191174

object_name: refractory hematologic cancer


subject: CHEBI:191174

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:191174

object_name: Plasma cell myeloma refractory


subject: CHEBI:191174

object_name: Metastatic Breast Carcinoma


subject: CHEBI:191174

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:191174

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:191174

object_name: anemia


subject: CHEBI:191174

object_name: Anemia, CTCAE


subject: CHEBI:191174

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: Stage IV Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:135402009

object_name: myelodysplastic syndrome with ring sideroblasts


subject: PUBCHEM.COMPOUND:135402009

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:135402009

object_name: Leukemia, Myeloid, Chronic-Phase


subject: PUBCHEM.COMPOUND:135402009

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:135402009

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: PUBCHEM.COMPOUND:135402009

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:135402009

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: PUBCHEM.COMPOUND:135402009

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Chronic Lymphoid Leukemia


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Myeloproliferative Neoplasm


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Hematologic Malignancy


subject: PUBCHEM.COMPOUND:135402009

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:135402009

object_name: B-cell small lymphocytic lymphoma recurrent


subject: PUBCHEM.COMPOUND:135402009

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage III Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Refractory Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:135402009

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:135402009

object_name: Refractory Primary Myelofibrosis


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IV Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Refractory Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage III Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Stage IV Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: refractory hematologic cancer


subject: PUBCHEM.COMPOUND:135402009

object_name: Non-Hodgkin's lymphoma refractory


subject: PUBCHEM.COMPOUND:135402009

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:135402009

object_name: Metastatic Breast Carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Refractory Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: Refractory Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135402009

object_name: anemia


subject: PUBCHEM.COMPOUND:135402009

object_name: Anemia, CTCAE


subject: PUBCHEM.COMPOUND:135402009

object_name: myelofibrosis


subject: CHEBI:15640

subject_name: Leucovorin

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:15640

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:15640

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:15640

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:15640

object_name: Blast Phase


subject: CHEBI:15640

object_name: castration-resistant prostate carcinoma


subject: CHEBI:15640

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:15640


subject: CHEBI:15640

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:15640

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:15640

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:15640

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:15640

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:15640

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:15640

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:15640

object_name: Plasma cell myeloma recurrent


subject: CHEBI:15640

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:15640

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:15640

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:15640

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:15640

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:15640

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:15640

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:15640

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:15640

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:15640

object_name: refractory hematologic cancer


subject: CHEBI:15640

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:15640

object_name: Plasma cell myeloma refractory


subject: CHEBI:15640

object_name: Metastatic Breast Carcinoma


subject: CHEBI:15640

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:15640

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:15640

object_name: anemia


subject: CHEBI:15640

object_name: Anemia, CTCAE


subject: CHEBI:15640

object_name: myelofibrosis


subject: CHEBI:63606

subject_name: Levoleucovorin

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:63606

object_name: myelodysplastic syndrome with ring sideroblasts


subject: CHEBI:63606

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:63606

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:63606

object_name: Blast Phase


subject: CHEBI:63606

object_name: castration-resistant prostate carcinoma


subject: CHEBI:63606

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63606


subject: CHEBI:63606

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: CHEBI:63606

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:63606

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:63606

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:63606

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:63606

object_name: Recurrent Myeloproliferative Neoplasm


subject: CHEBI:63606

object_name: Recurrent Hematologic Malignancy


subject: CHEBI:63606

object_name: Plasma cell myeloma recurrent


subject: CHEBI:63606

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:63606

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: CHEBI:63606

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:63606

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:63606

object_name: Stage III Non-Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Refractory Acute Lymphoblastic Leukemia


subject: CHEBI:63606

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:63606

object_name: Refractory Primary Myelofibrosis


subject: CHEBI:63606

object_name: Stage IV Non-Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Refractory Malignant Solid Neoplasm


subject: CHEBI:63606

object_name: Stage III Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Stage IV Hodgkin Lymphoma


subject: CHEBI:63606

object_name: refractory hematologic cancer


subject: CHEBI:63606

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:63606

object_name: Plasma cell myeloma refractory


subject: CHEBI:63606

object_name: Metastatic Breast Carcinoma


subject: CHEBI:63606

object_name: Refractory Hodgkin Lymphoma


subject: CHEBI:63606

object_name: Refractory Childhood Hodgkin Lymphoma


subject: CHEBI:63606

object_name: anemia


subject: CHEBI:63606

object_name: Anemia, CTCAE


subject: CHEBI:63606

object_name: myelofibrosis